Glenmark Pharmaceuticals reports 24.34% fall in Q1 net profit

02 Aug 2012 Evaluate

Glenmark Pharmaceuticals has reported results for first quarter ended June 30, 2012.

On standalone basis, the company has reported a fall of 24.34% in its net profit at Rs 54.82 crore for the quarter, as compared to Rs 72.46 crore for the same quarter in the previous year.  However, total income of the company has increased by 17.90% to Rs 404.69 crore for the quarter under review as compared to Rs 343.24 crore for the quarter ended June 30, 2011.

On the consolidated basis, the company has reported a fall of 62.47% in its net profit at Rs 78.27 crore for the quarter, as compared to Rs 208.58 crore for the same quarter in the previous year. However, total income of the company has increased by 18.43% to Rs 1043.29 crore for the quarter under review as compared to Rs 880.89 crore for the quarter ended June 30, 2011.

Glenmark Pharma Share Price

2009.10 2.20 (0.11%)
30-Dec-2025 11:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.60
Dr. Reddys Lab 1268.25
Cipla 1487.45
Zydus Lifesciences 902.25
Lupin 2083.80
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×